Indian hospitals have seen a large impact due to the COVID-19 pandemic, especially among small and medium-sized healthcare providers, said a Nathealth study.
Aster DM Healthcare Limited, through its wholly owned subsidiary companies, has acquired 100 percent of Warseps Healthcare LLP.
Industry body FICCI, while welcoming the steps towards Atmanirbhar Bharat, stated that public spending on healthcare should be increased to at least 2.5% of GDP, which has been assured in the National Health Policy 2017.
The private healthcare sector is expected to witness short term operating losses to the tune of Rs 14,000 to Rs 24,000 crore for a quarter due to the outbreak of COVID-19 and the subsequent lockdown in India.
Credit rating agency ICRA Ratings has estimated the impact of COVID-19 on the hospital industry to be negative in the short-term.
Fortis Healthcare has earmarked a total of 262 beds to treat COVID-19 patients and set up isolation wards in all of its 28 hospitals across the country.
COVID-19 National Teleconsultation Centre (CoNTeC) has been launched at the All India Institute of Medical Sciences (AIIMS), New Delhi, recently.
KIMS Healthcare group has opened a new medical centre at Manacaud in Trivandrum, as part of its expansion activities in the capital city.
Tattvan, a telemedicine healthcare e-clinic, has launched ‘Second Medical Opinion’ service for multispecialty advanced care patients across India.
Hinduja Hospital recently hosted the 9th annual joint leadership meeting of RePORT India Consortium under the Department of Biotechnology (DBT) and the National Institute of Health, (NIH) USA at Mumbai.
Binita Ashar, MD, of the FDA’s Centre for Devices and Radiological Health issued a statement on known risk of lymphoma from breast implants.
Payam A. Gammage et al reported the first in vivo successes in using zinc finger nucleases (ZFN) for selectively editing away pathogenic mitochondrial DNA (mtDNAs) in a heteroplasmic mammalian mitochondrial population.
